Engineered lipid nanoparticles enable therapeutic gene silencing of GTSE1 for the treatment of liver fibrosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Engineered lipid nanoparticles enable therapeutic gene silencing of GTSE1 for the treatment of liver fibrosis

Published:2024-10 Issue: Volume:374 Page:337-348
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Jeong Michaela,Shin Sumin,Lee Gyeongseok,Lee Yeji,Park Seo Bhin,Kang Jisoo,Lee Young-Sun,Seo Wonhyo,Lee Hyukjin

Funder

National Center for Inter-University Research Facilities

Ministry of Food and Drug Safety

Korea Ministry of Science and ICT

Publisher

Elsevier BV

Reference41 articles.

1. The limitless future of RNA therapeutics;Damase;Front. Bioeng. Biotechnol.,2021

2. mRNA-based therapeutics: powerful and versatile tools to combat diseases;Qin;Signal Transduct. Target. Ther.,2022

3. Lipid nanoparticles for nucleic acid delivery: current perspectives;Samaridou;Adv. Drug Deliv. Rev.,2020

4. Lipids and lipid derivatives for RNA delivery;Zhang;Chem. Rev.,2021

5. Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases;Wynn;J. Clin. Invest.,2007

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP